Avista Pharma Solutions Names New CFO

Avista Pharma Solutions has appointed Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer is a finance and operations executive with over twenty years of experience in various roles within growing technology and life science companies. Prior to joining Avista Pharma, he served as the Executive Director of Finance at INC Research, a publicly traded clinical research organization in Raleigh, NC. Previously, Mr. Setzer served as CFO of Expression Analysis, a genomics service provider located in Research Triangle Park, NC which was sold to Quintiles in 2012. Mr. Setzer was also CFO of three separate venture capital-funded companies in the health care technology sector, and he was the controller of TriPath Imaging, a publicly traded cervical cytology screening company.  Mr. Setzer began his career in public accounting, working for Price Waterhouse in Rochester, New York, and the Entrepreneurial Services Group of Ernst & Young inRaleigh, North Carolina.

"We are delighted to have Eric join our dynamic team at a time when Avista Pharma is expanding our contract services," said Mr.Patrick Walsh, Chief Executive Officer (CEO) of Avista Pharma. "We continue to advance an aggressive growth and acquisition strategy and Eric's experience and leadership will add value to the company."

"I am excited to join Avista Pharma at such a key stage of growth," said Mr. Setzer. "Avista Pharma is already a top-tier company in the CDMO sector, and I look forward to being part of a dynamic growth opportunity."

Mr. Setzer received his MBA from Duke University, has an undergraduate degree in Accounting and Economics from Oswego State University and is a licensed Certified Public Accountant.